Introduction
============

Efficacious wound healing is still a clinical challenge and the complications associated with impairment in wound healing carry a great financial burden as well as a negative impact on patient lifestyle. Among chronic wounds, the highest prevalence lays in the venous leg ulcer, diabetic foot/leg wound (DFU), and pressure ulcer categories. Complex chronic wounds, such as diabetic ulcers, have a major long-term impact on the morbidity, mortality, and quality of patient's life. In 2010, the NHS in England has spent around £650 million on foot ulcer management and amputation, which represent \~0.5% of its budget.[@b1-jmdh-10-179] In the USA, 33% of the \$116 billion total health care spend on diabetes is on the management of foot ulceration.[@b2-jmdh-10-179] In Europe, cost of wound management accounts for 2%--4% of the health care budgets.[@b3-jmdh-10-179] Furthermore, Diabetes UK estimates that by 2030, nearly 552 million people worldwide will develop diabetes.[@b4-jmdh-10-179] Estimates indicate that 15% of all diabetes patients will develop DFUs and of that 84% leading to lower leg amputations.

The wound healing process is influenced by several local and systemic factors[@b5-jmdh-10-179],[@b6-jmdh-10-179] ([Figure 1](#f1-jmdh-10-179){ref-type="fig"}), and is complex with a multitude of biomolecular pathways, but comprises four distinct yet interrelated phases: hemostasis, inflammation, proliferation, and remodeling ([Figures 2](#f2-jmdh-10-179){ref-type="fig"} and [3](#f3-jmdh-10-179){ref-type="fig"}). The human epidermis exhibits a natural endogenous "battery" that generates a small electric current when wounded.[@b7-jmdh-10-179],[@b8-jmdh-10-179] Healing is arrested when the flow of current is disturbed or when the current flow is stopped during prolonged opening. Different treatment strategies exist for the management of chronic wounds; some are invasive, such as wound debridement and skin substitute therapy, while others are noninvasive, such as compression bandaging, wound dressing, hyperbaric oxygen therapy, negative pressure therapy, ultrasound, and electrostimulation therapy (EST). EST is relatively cost-effective, safe, painless, and easy to use. EST mimics the natural current of injury and jump starts or accelerate the healing process.

The effect of electrical stimulation (ES) has been tested in vitro on different types of cells involved in wound healing, such as macrophages,[@b9-jmdh-10-179] fibroblasts,[@b10-jmdh-10-179]--[@b14-jmdh-10-179] epidermal cells,[@b15-jmdh-10-179]--[@b20-jmdh-10-179] bacteria,[@b21-jmdh-10-179]--[@b23-jmdh-10-179] and endothelial cells[@b24-jmdh-10-179]--[@b26-jmdh-10-179] that have demonstrated changes in cell migration, proliferation, and orientation, increase in proteins and DNA synthesis, and antibacterial effects. When applied on in vivo models[@b27-jmdh-10-179]--[@b40-jmdh-10-179] and clinical stud ies,[@b41-jmdh-10-179]--[@b61-jmdh-10-179] EST has shown positive effects on wound closure and healing rate. Other outcomes, such as increased angiogenic response, wound contraction, and antibacterial effects have also been reported. However, there is a considerable variation in study design, outcome measures, ES parameters, type of current, type of wound, and treatment duration, and dose, thus presenting further questions on the most optimal approach for the treatment of cutaneous wound healing is crucial. This review presents an overview of the state-of-the-art medical technology applications and technologies associated with "smart" materials that can be potentially exploited to mimic the current of injury for wound healing and skin regeneration, with reports on the therapeutic evidences of their present use in clinical practice.

Endogenous bioelectric current
==============================

It is known that the human body possesses an endogenous bioelectric system that produces natural electrochemical signals in different areas, such as the brain, skin, muscles, heart, and bones. In physiological solution, there are no free electrons to carry the current. Thus, it is carried by charged ions. Across the tissues, asymmetric ionic flows generate electrical potentials ([Figure 4A](#f4-jmdh-10-179){ref-type="fig"}). A transepithelial electric potential, named skin battery, is generated by the movement of ions through Na^+^/K^+^ ATPase pumps of the epidermis.[@b20-jmdh-10-179]

Current of injury, which is essential for normal wound healing ([Figure 4B](#f4-jmdh-10-179){ref-type="fig"} and [Video S1](#SD1-jmdh-10-179){ref-type="supplementary-material"}), is generated during skin injury. This electrical leak, which is a long-lasting lateral electrical potential, short-circuits the skin battery. Ca^2+^, Na^+^, K^+^, and Cl^−^ ions are the main components of this electrical current.[@b62-jmdh-10-179] The current of injury, measurable 2--3 mm around the wound and from around 10 to 60 mV,[@b8-jmdh-10-179] creates an electrical potential directed toward the wound with the negative pole at the wound center and the positive at the edge[@b20-jmdh-10-179],[@b63-jmdh-10-179] and attracts cells toward the injury. The current is sustained in a moist environment and shuts off when a wound dries out.[@b64-jmdh-10-179] The link between ionic flux, current of injury, and healing rate has been made in 1983. Increase in Cl^−^ and Na^+^ influx with AgNO~3~ in wounded corneal epithelium of rats induced a significant augmentation of the current of injury, resulting in enhanced wound healing. However, rat corneal wounds with furosemide (a component that inhibits Cl^−^ efflux) exhibited a significant diminution of the current of injury, resulting in impaired corneal wounds.

Effects of exogenous electric current on wound healing
======================================================

ES is used in several disciplines, such as electroanalgesia for chronic pain control, pacemakers to regulate heartbeat, cochlear stimulation to aid hearing, functional ES to restore mobility in people with paralyzed limb(s), in addition to enhance wound healing.[@b65-jmdh-10-179] In wound healing, four main therapeutic approaches have been identified: direct current (DC), alternative current (AC), pulsed current (PC), and transcutaneous electrical nerve stimulation (TENS; [Figure 5A](#f5-jmdh-10-179){ref-type="fig"}). In each therapeutic approach, different parameters, such as the voltage, duration, frequency, phase, mode, and type of pulse, can be controlled. Depending on the protocol, the impulse amplitude is either preset by the operator at the maximum value according to the patient's sensitivity threshold of the stimulated tissue or can be changed by the patient during the treatment according to personal sensitivity. DC is continuous and simple. If DC is applied for a too long duration and amplitude, DC can cause tissue irritation and damage. On a porcine wound, AC and DC both reduced healing time.[@b37-jmdh-10-179] However, DC seemed to be more efficient than AC to reduce the wound area, and AC seemed to be more efficient than DC to reduce the wound volume.

PC is one of the most documented EST. In clinical trials, low voltage, high voltage, degenerative waveform, and short voltage PC (SVPC) have shown positive effects when used on diabetic and chronic ulcers.[@b43-jmdh-10-179]--[@b51-jmdh-10-179],[@b55-jmdh-10-179],[@b61-jmdh-10-179] One randomly controlled clinical trial (RCT) has tested different durations of stimulation on ulcer patients and showed that 60 and 120 min of stimulation significantly reduced the wound surface area compared to 45 min.[@b42-jmdh-10-179] SVPC devices, such as Aptiva Ballet (Lorenz Therapy system) or Naturepulse (Globe Microsystems), generate short voltage impulse patterns. Each impulse is characterized by a specific sharp spike. During the stimulation, frequency, pulse amplitude, and pulse width vary automatically. SVPC increases the circulating vascular endothelial growth factor (VEGF) in the blood during the stimulation and induces nitric oxide formation the day after treatment.[@b66-jmdh-10-179] Moreover, SVPC has shown enhanced wound area reduction in the treatment of chronic, venous, and diabetic ulcers, in four RCTs,[@b50-jmdh-10-179],[@b53-jmdh-10-179],[@b54-jmdh-10-179],[@b56-jmdh-10-179] but the short period of the studies has not allowed to evaluate the wound healing rate. One RCT[@b53-jmdh-10-179] has used SVPC on chronic leg ulcers with an "until-healed" treatment duration. This duration of treatment allowed to evaluate the wound closure and reported that SVPC enhanced wound closure. TENS is a low- or high-frequency pulsed electrical current that stimulates the peripheral nerves. This stimulation is used in clinical practice for the relief of chronic and acute pain. It is believed that stimulation of the peripheral nerves increases blood flow and could help healing. TENS locally increases the blood flow and VEGF level in healthy and diabetic patients.[@b67-jmdh-10-179]--[@b70-jmdh-10-179] However, no study has tested the effect of TENS on wound healing.

[Figure 5B](#f5-jmdh-10-179){ref-type="fig"} shows the summary of different methods of application. Electrodes can be placed next to or directly on the cutaneous wound. A portable and independent dressing can also recover the wound and deliver a small current.[@b71-jmdh-10-179] Electromagnetic field and wireless microcurrent stimulation can allow the user to deliver a broad stimulation under the skin without touching it directly, and both have shown promising results on chronic wounds.[@b60-jmdh-10-179],[@b71-jmdh-10-179],[@b72-jmdh-10-179] The optimal approach and relevant parameters for a given condition is yet to be determined. However, studies at the cellular and systemic level have already shown that EST affects several cells and events involved in wound healing ([Figure 6](#f6-jmdh-10-179){ref-type="fig"}). During inflammation, ES induces a faster inflammatory response[@b39-jmdh-10-179] and an increased vascular vasodilatation[@b73-jmdh-10-179] that increases tissue oxygenation,[@b37-jmdh-10-179] blood flow,[@b37-jmdh-10-179],[@b58-jmdh-10-179],[@b59-jmdh-10-179],[@b69-jmdh-10-179] and skin temperature.[@b59-jmdh-10-179] During the proliferation phase, ES generates increased angiogenesis,[@b30-jmdh-10-179],[@b36-jmdh-10-179],[@b57-jmdh-10-179],[@b59-jmdh-10-179] collagen matrix formation,[@b36-jmdh-10-179]--[@b38-jmdh-10-179] wound contraction,[@b29-jmdh-10-179],[@b57-jmdh-10-179] and reepithelialization.[@b57-jmdh-10-179],[@b60-jmdh-10-179] Finally, during the remodeling phase, increased cellular activity produces an advanced remodeling[@b57-jmdh-10-179] at a systemic level. RCT and in vivo trials have demonstrated the positive effects of EST on wounds ([Tables 1](#t1-jmdh-10-179){ref-type="table"} and [2](#t2-jmdh-10-179){ref-type="table"}).

ES cellular and molecular mechanisms
====================================

The mechanisms by which cells sense and respond to ES remain relatively unclear, it is believed that the extracellular electrical potential gradient generates an asymmetric signal between the two poles of the cells parallel to the electrical field lines. The cell membrane possesses an electrical potential that averages 70 mV and variation of this potential influences the cell's general activity. If the membrane is electrically quiescent, the cell downregulates and its functional capacity diminishes. Conversely, with increased levels of electrical activity, upregulation occurs and the general cell activity level increases.[@b26-jmdh-10-179] It is believed that by using ES, we can influence the electrical activity of the cell membrane and induce specific cellular responses. To evaluate how cells respond when exposed to an electrical current, experiments have been performed in electrotaxis chambers[@b74-jmdh-10-179] ([Figure 7](#f7-jmdh-10-179){ref-type="fig"}) and specifically designed culture plates.[@b75-jmdh-10-179],[@b76-jmdh-10-179] At the cellular level, EC may affect the ion channels and/or the membrane receptors, which constantly monitors the cell response to the microenvironment. Under an EC, both ion channels and transport proteins are activated and reorganized across the cell, independently of the external chemical gradient and ionic flow, to contribute toward intracellular polarization and cellular response.[@b77-jmdh-10-179] Intracellular pathways, such as phosphatidylinositol-3-OH kinase,[@b20-jmdh-10-179],[@b78-jmdh-10-179],[@b79-jmdh-10-179] and elements, such as golgi apparatus,[@b10-jmdh-10-179],[@b19-jmdh-10-179] seem to play a role in the galvanotaxis response.

Individually, each cell type exhibits specific behaviors under ES and no ES displays a significant reduction of cell viability or cytotoxic effect. First, the polarity of the EC directs the cell migration and splits them in two groups, the one migrating toward the anode and the one migrating toward the cathode ([Figure 8A](#f8-jmdh-10-179){ref-type="fig"}). In a monolayer organization, cells also exhibit polarity-dependent behaviors[@b19-jmdh-10-179],[@b20-jmdh-10-179] ([Figure 8B](#f8-jmdh-10-179){ref-type="fig"}). In a scratch assay, a monolayer of corneal epithelium cells moved into the wounds in a coordinated manner without EC and faster with one that possessed the same polarity as the natural endogenous EC. Reversely, when applied opposite to the normal healing direction, the EC directed the cells at the wound edge, away from the wound, opening the wound. The same effect has been reported with a monolayer of fibroblasts[@b19-jmdh-10-179] ([Figure 8C](#f8-jmdh-10-179){ref-type="fig"}).

Furthermore, other outcomes have been used in vitro to measure the cell activity under EC. Under EC, fibroblasts proliferate, elongate, and reorient in vitro.[@b10-jmdh-10-179]--[@b12-jmdh-10-179],[@b14-jmdh-10-179] Electrically stimulated fibroblasts seem to have a higher contractile behavior and higher fibroblast to myofibroblast transdifferentiation.[@b11-jmdh-10-179] DC, AC, and PC have exhibited highly differential effects on fibroblasts in an in vitro study, where at high intensity and frequencies, the PC maximally downregulates collagen I and have a lower cytotoxic effect than AC and DC.[@b13-jmdh-10-179] At the wound site, enhanced fibroblast activities with DC, PC, and HVPC have also been reported in vivo, resulting in an increased fibroblast number,[@b29-jmdh-10-179],[@b39-jmdh-10-179] collagen synthesis,[@b13-jmdh-10-179],[@b29-jmdh-10-179],[@b33-jmdh-10-179],[@b36-jmdh-10-179],[@b38-jmdh-10-179] myofibroblast creation, and tensile strength.[@b29-jmdh-10-179] HVPC on diabetic rats has shown accelerated wound healing and restoration of the expression levels of collagen I and transforming growth factor, suggesting reactivation of the fibroblast activities.[@b33-jmdh-10-179] Under ES, vascular endothelial cells have also reported changes in cell elongation and orientation[@b24-jmdh-10-179]--[@b26-jmdh-10-179] and upregulation of the levels of VEGF and IL-8 receptors.[@b24-jmdh-10-179] Recent studies have also tested the effects of ES on macrophages that exhibit enhanced phagocytic activity[@b9-jmdh-10-179] and platelets that display growth factors releases.[@b80-jmdh-10-179]

Severe bacterial invasion can arrest the healing process and lead to chronic wound. Traditionally, systemic antibiotic treatments are used to treat severe infection. However, overuse of antibiotics can increase the bacterial resistance and lead to inefficient antibiotics. It is believed that ES may impose a bacteriostatic effect on microbes and bacteria that commonly colonize or infect wounds.[@b21-jmdh-10-179] Studies have shown that HVPC and DC kill or inhibit the proliferation of common wound pathogens,[@b22-jmdh-10-179],[@b23-jmdh-10-179] such as *Staphylococcus aureus*, *Escherichia coli*, and *Pseudomonas aeruginosa.* DC, HVPC, and LVPC have been tested in vitro on *S. aureus*.[@b23-jmdh-10-179] Apparently, HVPC and DC treatments have a significant inhibitory effect compared to LVPC. Moreover, no difference in bacterial growth inhibition was found when varying polarity and time of ES. At present, we are unclear as to why the ES seems to induce an antibacterial effect by direct or indirect mechanisms. The electrical current may directly disrupt the bacterial membrane or block its proliferation. Indirectly, the electrical current may induce a change of pH or temperature within the wound, a production of electrolysis products, or an increased migration of macrophages and leukocytes, resulting in an antibacterial effect.

Angiogenesis: friend or foe?
============================

Angiogenesis is a key event in wound healing. While insufficient angiogenesis can lead to chronic wound formation, aggressive angiogenesis can lead to abnormal scarring. Thus, spatiotemporal control of EST to enhance angiogenesis is crucial. Several studies on animal models and clinical trials have shown that ES increases the level of VEGF and the number of blood vessels in the wound.[@b30-jmdh-10-179],[@b58-jmdh-10-179],[@b59-jmdh-10-179],[@b66-jmdh-10-179],[@b73-jmdh-10-179] Higher levels of VEGF linked to enhancing angiogenesis and advanced healing have been reported in the stimulated arm of each patient. VEGF is the most used angiogenic marker as it presents all the characteristics of a specific angiogenic factor[@b81-jmdh-10-179] and is predominantly produced by macrophages, platelets, endothelial cells, epidermal cells, fibroblasts, myofibroblasts, and mast cells.[@b82-jmdh-10-179] Indirectly, increased angiogenesis can facilitate local tissue oxygenation.

Electrotherapy: the path to regeneration beyond repair?
=======================================================

Salamanders and newts exhibit impressive regenerative ability that is divided into three phases: wound healing, dedifferentiation, and redevelopment, where they can regrow a whole limb. Humans are limited in repairing the localized damaged area. Both human repair and regenerative processes are regulated by ionic flows and endogenous electrical current. However, the evolution of the endogenous electrical current is distinctly different in regenerating and nonregenerating species ([Figure 9](#f9-jmdh-10-179){ref-type="fig"}). In nonregenerative species, the positive current decreases simultaneously as the wound heals. However, in regenerative species, the initial positive polarity of the injured tissue sharply reverses to a high negative polarity that gradually reduces as the damaged area regenerates.[@b83-jmdh-10-179] Particularly, the regeneration of the limb seems to be stopped if the polarity of the electrical current does not reverse. Recently, an in vivo experimentation on 90 tendons of rabbits has linked variation in the healing response with the polarity of the exogenous ES.[@b27-jmdh-10-179] Even if both cathodal and anodal stimulation exhibited accelerated healing rate, cathodal (negative) ES showed more significant improvements than anodal (positive) ES in the first 3 weeks, while anodal ES showed more significant improvement after 3 weeks. Cathodal stimulation may promote and attract macrophages in the early stage of wound healing, resulting in a faster inflammatory phase, and anodal stimulation may promote and attract fibroblasts in the late stage of wound healing, resulting in advanced remodeling phase. Recognition of the ES polarity dependence on the stage of the wound could lead to better healing response and less scar formation.

Smart materials, technology, and ES
===================================

Electrotherapy could be combined with the state-of-the-art technologies for potentially superior therapeutic effects in wound healing and skin regeneration ([Figure 10](#f10-jmdh-10-179){ref-type="fig"}). For instance, researchers have set up human skin-based triboelectric nanogenerators[@b84-jmdh-10-179] and smart skins[@b85-jmdh-10-179] that can harvest the biomechanical energy to produce renewable electricity. Such technologies could power a bioelectric dressing that would stimulate the wound. New dressings made of conductive and inherently antibacterial materials, such as electroactive doped polyurethane/siloxane membrane,[@b86-jmdh-10-179] can work simultaneously with electrotherapy by restoring the physiological homeosta-sis at the wound site and biomimicking the current of injury. Moreover, electrically controlled drug delivery could be achieved within a dressing or scaffold by using electrically responsive hydrogels[@b87-jmdh-10-179],[@b88-jmdh-10-179] or graphene oxide nanocomposite films[@b89-jmdh-10-179] filled with nanoparticle system containing the drug. With this approach, drug release could be modulated by the endogenous or exogenous electrical current. Using a scaffold, such as collagen/gold nanoparticle scaffolds[@b90-jmdh-10-179] or injectable microporous gel scaffolds,[@b91-jmdh-10-179] could provide a biodegradable structure and accelerate cell migration to the wound site, following which an ES can enhance the cellular activity within the scaffold. Specific materials properties can be combined with EST for better aesthetics of the wound during the treatment, by creating a layer on the skin to disguise or "hide" the wound.[@b92-jmdh-10-179] 3D printing is a relatively novel method that enables bespoke therapy and offers an opportunity to 3D print skin scaffolds using the patient's own cells[@b93-jmdh-10-179] as well as the ability to make bespoke patches.[@b94-jmdh-10-179] Shape memory polymer composites,[@b95-jmdh-10-179] which have properties similar to uninjured skin, are of great interest to generate electricity-dependent mechanical and thermal stresses on the wound. These stresses would depend on the intensity of the current of injury, and thus, would evolve during each phase of the healing process.

Role of magnetic field
======================

Furthermore, significant beneficial effects have been reported with the use of magnetic field in pain management, bone fracture, and wound healing.[@b96-jmdh-10-179] It is particularly intriguing when we know that magnetic and electric forces are linked by the Maxwell's equations. Every electric field generates a magnetic field in the surrounding environment and vice versa. Scientists refer to the use of electric and magnetic fields in medicine as the electromagnetic field therapy.[@b96-jmdh-10-179] In vitro, magnetic field seems to elicit changes in cells of the immune systems through Ca^2+^ signaling, including upregu-lated cytokine synthesis and increased cell proliferation. The electromagnetic field generates an ionic flow under the skin that is similar to the one seen in electrotherapy. However, more studies are needed to understand the mechanisms underlying the response of biological tissue to both electric and magnetic fields.

Conclusion and the future
=========================

Electrotherapy and associated smart materials and technologies promise to improve chronic wound healing strategies and can be potentially established as a clinically robust and commercially viable system for wound healing that will make a great impact in global health care and economy. However, there are considerable variations in parameters, modes, dosing, and duration of treatment that lead to complications in comparison of the data with a need for more well-designed clinical trials.

The healing process undergoes different stages and each stage involves a different and interlinked set of cellular events. More studies are warranted to delineate their mechanism and the influence of ES on them. Recognizing the type of current and the corresponding cellular activity, which it most influences may help to present personalized treatment to specific types of wounds. Electrotherapy devices at the current age of digital health care, together with developments in responsive smart materials and technologies, could enable continuous monitoring of the status of patient's wound, allowing instant feedback responses, thus allowing the health care provider to choose with ease, preselected parameters that would optimally accelerate wound healing. These possible innovations could have an impact on other related diseases, such as Raynaud's disease, necrotizing fasciitis, or cosmetic concerns, such as chickenpox scars, acne, keloid scar, or rosacea. Better understanding and optimization of EST will interest multidisciplinary research groups including surgical, biochemical and translational sciences to apply the great potential of EST in regenerative medicine.

Supplementary material
======================

###### 

[Video S1](https://www.youtube.com/watch?v=UHadO6X0WAc) The skin battery and the current of injury.
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![Local and systemic factors that influence wound healing](jmdh-10-179Fig1){#f1-jmdh-10-179}

![Hemostasis and inflammation phases of wound healing.\
**Notes:** After an injury, the hemostasis (yellow) leads to cessation of bleeding. The platelets adhere to form a clot and release mediators to induce additional platelet aggregation and mediate the phases of the healing process. The released mediators trigger the inflammatory phase (orange), divided into a vascular and a cellular response. Neutrophils, macrophages, and lymphocytes are cleaning the wound while the surrounding vascular system dilates, allowing more blood volume and circulating cells to be recruited. Neutrophils and macrophages migrate toward the wound in order to clear the area of debris, bacteria, and dead tissues, also known as phagocytosis. In addition to providing cellular immunity and antibody production, lymphocytes act as mediators within the wound environment through the secretion of cytokines and direct cell-to-cell contact.](jmdh-10-179Fig2){#f2-jmdh-10-179}

![Proliferation and remodeling phases of wound healing.\
**Notes:** The proliferation phase (blue) is a reconstruction step, where cells are working to form granulation tissues and restore a functional skin. Several events are conducted simultaneously: angiogenesis, granulation tissue formation, wound contraction, collagen deposition, and reepithelialization. Activated endothelial cells create new blood vessels by proliferating and migrating toward the source of the angiogenesis stimulus. The epidermal cells proliferate and migrate at the wound edge to initiate wound recovery. Stimulated fibroblasts synthesize collagen, ground substance, and provisional matrix to create a collagen-based scar tissue. Some of them also differentiate into myofibroblast that contracts and induces mechanical stress inside the wound. During the remodeling phase (green), the matrix is turned over and the wound undergoes more contraction by the myofibroblasts. Collagen is also reorganized and reoriented.](jmdh-10-179Fig3){#f3-jmdh-10-179}

![Cutaneous endogenous bioelectric current before and after injury.\
**Notes:** Unbroken skin layers of the epidermis and dermis (**A**) maintain the skin battery across the body through ionic movement of Na^+^, K^+^, and Cl−, generating a polarity with positive (+) and negative (−) poles. When wounded (**B**), the current flows out of the wound (blue), generating an endogenous electrical potential (green) with the negative pole (−) in the wound center and the positive pole away from the wound (+). These changes can be viewed in [Video S1](https://www.youtube.com/watch?v=UHadO6X0WAc). Data from Zhao et al.[@b20-jmdh-10-179]](jmdh-10-179Fig4){#f4-jmdh-10-179}

![Types of electrical current and their different methods of application.\
**Notes:** Four main types of current have been identified (**A**). Direct current (orange) is a continuous, unidirectional flow of charged particles that has no pulses and no waveform. DC is characterized by an amplitude and a duration. Its polarity remains constant during the stimulation. Alternative current (green) is a continuous bidirectional flow of charged particles in which a change in direction of flow occurs. AC stimulation is characterized by an amplitude, duration, and frequency. Pulsed current is a brief unidirectional or bidirectional flow of charged particles composed of short pulses separated by a longer off period of no current flow. PC stimulation is characterized by a frequency, duration, and pulse. The pulse is defined by a waveform, amplitude, and duration. The waveform can be monophasic (yellow), with constant polarity, or biphasic (blue), with alternating polarity. Electrical current can stimulate wound healing through different type of applications (**B**): electrodes on the skin, bioelectric dressing, wireless current stimulation, and EMF.\
**Abbreviations:** EMF, electromagnetic field; DC, direct current; AC, alternative current; PC, pulsed current.](jmdh-10-179Fig5){#f5-jmdh-10-179}

![Reported effects of ES on wound healing at the cellular and systemic level during inflammation (yellow), proliferation (blue), and remodeling (green).\
**Notes:** During inflammation, ES increases macrophages migration and activity and decreases bacterial proliferation at the cellular level. At a systemic level, it induces a faster inflammatory response and an increased vascular vasodilatation that increases tissue oxygenation, blood flow, and skin temperature. During the proliferation phase, ES increase the migratory response and activity level of epidermal cells, endothelial cells, fibroblasts, and myofibroblasts. At the systemic level, it generates increased angiogenesis, collagen matrix formation, wound contraction, and reepithelialization. Finally, during the remodeling phase, the activity of fibroblasts and myofibroblasts is enhanced at a cellular level and produces an advanced remodeling at a systemic level.\
**Abbreviation:** ES, electrical stimulation.](jmdh-10-179Fig6){#f6-jmdh-10-179}

![This experimental setup has been reported by Farina et al[@b70-jmdh-10-179] and has been used in several other articles.\
**Notes:** The cell culture (blue) is done within an electrotactic chamber that isolates it from the outside (usually a modified well plate). The electrodes from the ES device are stimulating the cells through a conductive interface (blue) to the cell culture to avoid any electrochemical products in the cell culture. The electricity delivered is followed with an electrical measurement system (yellow), such as an oscilloscope. Finally, the evolution of the cells is tracked with a microscope (green) and the images are stored in a computer. Data from Song et al.[@b74-jmdh-10-179] **Abbreviation:** ES, electrical stimulation.](jmdh-10-179Fig7){#f7-jmdh-10-179}

![The polarity of the electrical current is a key feature in wound healing.\
**Notes:** In isolated cell culture, neutrophils, vascular endothelial cells, and macrophages migrate toward the anode, and monocytes, fibroblasts, and epidermal cells toward the cathode (**A**). The polarity of the applied electrical current directly affects the direction of the cell migration on a scratch assay with a monolayer of corneal epithelial cells (**B**) and fibroblasts (**C**). Figure **B** adapted by permission from Macmillan Publishers Ltd: *Nature*. Zhao M, Song B, Pu J, et al. Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN. 2006;442(7101):457--460. Copyright 2006. Available from <http://www.nature.com/>.[@b20-jmdh-10-179] Figure **C** data from Pu and Zhao.[@b19-jmdh-10-179]](jmdh-10-179Fig8){#f8-jmdh-10-179}

![Evolution of the current of injury in regenerative and nonregenerative species after injury (**A**). In nonregenerative species (blue), the current stays positive and gradually reduces as the wound heals. In regenerative species (red), a polarity reversal (green) occurs while healing. The negative current gradually reduces as the damaged area regenerates. After an injury (**B**), both regenerative and nonregenerative species exhibit a healing process. After the polarity reversal of the regenerative species, a dedifferentiation, where cells lose their specialized characteristics and migrate, occurs. Then the limb regrows during the redevelopment and leads to a complete regeneration, where nonregenerative species have maintained their positive current and repaired tissues with a scar.](jmdh-10-179Fig9){#f9-jmdh-10-179}

![Electrotherapy can be combined with state of the art technology, such as active dressings, 3D printing, scaffold, drug delivery, or smart skin.\
**Abbreviation:** ES, electrical stimulation.](jmdh-10-179Fig10){#f10-jmdh-10-179}

###### 

Animal in vivo studies testing the effects of electrical stimulation on wound healing

  Type of ES                   Type of wound             Animal   Results
  ---------------------------- ------------------------- -------- ----------------------------------------------------------------------------------------------------------------------------
  DC[@b35-jmdh-10-179]         Incision wound            Pig      Increased wound closure, increase of fibroblasts collagen, no difference in microvessel number
  DC[@b39-jmdh-10-179]         Incision wound            Rat      Decrease of PMN and macrophages, increase of fibroblasts
  DC or AC[@b37-jmdh-10-179]   Incision wound            Pig      Reduced healing time and increased perfusion, DC reduced wound area more rapidly, AC reduced the wound volume more rapidly
  DC or PC[@b28-jmdh-10-179]   Incision wound            Rat      Increased biomechanical properties, collagen density, and wound closure
  PC[@b31-jmdh-10-179]         Incision wound            Mice     Acceleration of healing in 0.9--1.9 kV/m and suppression in 10 kV/m
  PC[@b40-jmdh-10-179]         Diabetic excision wound   Mice     Altered collagen deposition and cell number
  PC[@b35-jmdh-10-179]         Incision wound            Pig      Greater and faster wound surface area
  PC[@b29-jmdh-10-179]         Incision wound            Rabbit   Increased number of fibroblasts and higher tensile strength
  PC[@b30-jmdh-10-179]         Incision wound            Rat      Increase of blood vessels and fibroblasts
  PC[@b33-jmdh-10-179]         Diabetic incision wound   Rat      Increase wound healing, upregulation of collagen I and TGF
  PC[@b36-jmdh-10-179]         Ischemic model            Rabbit   Increase of VEGF and collagen IV and activity of collagen I and V
  TENS[@b34-jmdh-10-179]       Skin flap                 Rat      Increased wound closure
  TENS[@b32-jmdh-10-179]       Incision wounds           Rats     Proinflammatory cytokines reduction, and increased wound closure, reepithelialization, and granulation tissue formation

**Abbreviations:** AC, alternative current; DC, direct current; ES, electrical stimulation; PC, pulsed current; PMN, polymorphonuclear leukocytes; TENS, transcutaneous electrical nerve stimulation; TGF, transforming growth factor; VEGF, vascular endothelial growth factor.

###### 

Clinical trial studies about EST on wound healing

  Type of ES               Equipment                                                               Design             Blinding               Type of wound                                Duration (days)   Structure                                                 Patients (n)   ES parameters       ES effects                                                                                                   
  ------------------------ ----------------------------------------------------------------------- ------------------ ---------------------- -------------------------------------------- ----------------- --------------------------------------------------------- -------------- ------------------- ----------------- ------------------------------------------------------------------------------------------ ----------------------------------------------
  DC[@b60-jmdh-10-179]     WMCS device (Wetling, Friedensborg, Denmark)                            Control            Not reported           Mixed ulcers                                 56                2--3 times weekly, 45--60 min                             47             47                  NA                1.5 µA                                                                                     WAR
  DC[@b41-jmdh-10-179]     Not reported Stimulation (Henley International, Houston, TX, USA)       RCT                Double-blind placebo   Pressure ulcers                              56                20 min, 3 times daily, then 2 times daily after 14 days   63             35                  28                Not reported                                                                               Wound closure and WAR
  AC[@b52-jmdh-10-179]     Electrical Nerve                                                        RCT                Single-blind           Diabetic venous ulcers                       84                20 min, 2 times per day                                   64             24                  27                80 Hz, 1 ms pulse width                                                                    Wound closure and WAR
  PC[@b51-jmdh-10-179]     Biopac MP100 (Biopac Systems, Goleta, CA, USA)                          RCT reported       Not                    Chronic wounds of diabetic and nondiabetic   28                3 times per week                                          20             20                  0                 5 V, pulse width 200 µs, 30 Hz, 20 mA                                                      Higher WAR in diabetics than in nondiabetics
  LVPC[@b43-jmdh-10-179]   Experimental direct current generator                                   Retrospective      Not reported           Mixed ulcers                                 35                2 h, 5 days a week                                        30             15                  15                300--500 µA or 500--700 µA                                                                 WAR
  LVPC[@b61-jmdh-10-179]   MEMS CS 600 (Harbor Medical Inc, Minneapolis, MN, USA)                  Placebo            Double-blind           Pressure ulcers                              56                3 times weekly                                            78             41                  30                300--600 µA, 0.8 pps                                                                       Wound closure
  HVPC[@b44-jmdh-10-179]   Vara/pulse stimulator (Staodynamics Inc, Longmont, CO, USA)             RCT                Double-blind           Mixed ulcers                                 28                30 min, 2 times daily                                     47             26                  24                29.2 V, maximum 29.2 µA, 64--128 pps                                                       WAR
  HVPC[@b45-jmdh-10-179]   Ionoson (Physiomed, Essen, Germany)                                     RCT                Not reported           Pressure ulcers                              42                50 min, 5 days a week                                     50             26                  24                100 V; 100 µs; 100 Hz)                                                                     WAR
  HVPC[@b46-jmdh-10-179]   Ionoson (Physiomed, Essen, Germany)                                     RCT                Not reported           Venous leg ulcers                            42 week           50 min, 6 days a                                          76             62                  14                100 V, 100 pps, monophasic                                                                 WAR
  HVPC[@b47-jmdh-10-179]   Intelect 500 HVPC stimulator (Chattanooga Corp, Chattanooga, TN, USA)   RCT                Single-blind placebo   Pressure ulcers                              20                1 h daily                                                 17             8                   9                 100 pps, 200 V, 500 µA                                                                     WAR
  HVPC[@b48-jmdh-10-179]   Micro Z (Prizm Medical Inc, Duluth, GA, USA)                            RCT                Single-blind           Pressure ulcers                              90                Around 3 h daily                                          34             16                  18                50 µs pulse duration, 50--150 V, 20 min at 100 Hz, 20 min at 10 Hz, and 20 min off cycle   Wound closure and WAR
  HVPC[@b49-jmdh-10-179]   EGS Model 300 (Electro-Med Health Industries, North Miami, FL, USA)     RCT                Double-blind           Mixed ulcers                                 28                45 min, 3 times a week                                    27             14                  13                100 µs, 150 V, 100 Hz                                                                      WAR
  HVPC[@b55-jmdh-10-179]   Micro-Z (Prizm Medical Inc, Duluth, GA, USA)                            RCT                Double-blind           Diabetic foot ulcers                         84                8 h daily                                                 40             20                  20                50 V, 100 µs, 80 pps for 10 min then 8 pps for 10 min, and 40 min standby cycles           Wound closure and WAR
  SVPC[@b50-jmdh-10-179]   Aptiva Ballet (Lorenz Terapy System, Lorenz Biotech, Medolla, Italy)    RCT                Not reported           Mixed ulcers                                 21                40 min daily, 5 days a week                               35             20                  15                300 V, 1000 Hz, 10--40 µs, 100--170 µA                                                     WAR
  SVPC[@b53-jmdh-10-179]   Aptiva Ballet (Lorenz Therapy System, Lorenz Biotech, Medolla, Italy)   RCT                None                   Chronic leg ulcers                           Until healed      3 per week for 4 weeks, followed by 2 weeks rest          60             30                  30                0--300 V, 1--1000 Hz, 10--40 µs, 100--170 µA                                               Wound closure and reduction of pain
  SVPC[@b54-jmdh-10-179]   Aptiva Ballet (Lorenz Therapy System, Lorenz Biotech, Medolla, Italy)   RCT                None                   Diabetic foot ulcers                         30                30 min, every 2 days                                      30             16                  14                0--300 V, 1--1000 Hz, 10--40 µs, 100--170 µA                                               WAR
  SVPC[@b56-jmdh-10-179]   Aptiva Ballet (Lorenz Therapy System, Lorenz Biotech, Medolla, Italy)   RCT                Not reported           Venous ulcers                                21                25 min, 5 days a week                                     20             10                  10                0--300 V, 1--1000 Hz, 10--40 µs, 100--170 µA                                               WAR
  SVPC[@b59-jmdh-10-179]   Fenzian system (Fenzian Ltd, Hungerford, UK)                            RCT                None                   Healthy volunteers, acute wounds             90                4 times during the second week                            40             40 treatment arms   40 control arms   0.004 mA, 20--80 V, 60 Hz, degenerative waves                                              Increase angiogenic response
  SVPC[@b58-jmdh-10-179]   Fenzian system (Fenzian Ltd, Hungerford, UK)                            Controlled study   None                   Healthy volunteers, acute wounds             90                4 times during the second week                            20             20 treatment arms   20 control arms   0.004 mA, 20--80 V, 60 Hz, degenerative waves                                              Increase blood flow and hemoglobin levels

**Abbreviations:** CON, control; DC, direct current; ES, electrical stimulation; EST, electrostimulation therapy; HVPC, high-voltage pulsed current; LVPC, low-voltage pulsed current; SVPC, short-voltage pulsed current; RCT, randomized controlled trial; Tx, treatment; WAR, wound area reduction.
